Literature DB >> 26568146

The management of head and neck tumors with high technology radiation therapy.

Lucas Castro Mendez1, Fabio Ynoe Moraes2,3, Ian Poon4, Gustavo Nader Marta.   

Abstract

Squamous cell carcinoma is responsible for 90% of the head and neck cancers affecting over 600,000 people worldwide. Radiation therapy, surgery and chemotherapy are the most important treatment modalities in head and neck squamous cell carcinoma. The aim of this review is to summarize the recent innovations in head and neck radiation therapy, which intends to appreciate the cutting-edge intensity-modulated radiation therapy strategies to mitigate long-term toxicities and evaluate promising technologies in the field as adaptive treatment, dose painting and proton therapy.

Entities:  

Keywords:  Head and neck cancer; quality of life; radiation therapy; toxicity; treatment

Mesh:

Year:  2015        PMID: 26568146     DOI: 10.1586/14737140.2016.1121111

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  8 in total

1.  Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.

Authors:  Molly K Barnhart; Bena Cartmill; Elizabeth C Ward; Elizabeth Brown; Jonathon Sim; George Saade; Sandra Rayner; Rachelle A Robinson; Virginia A Simms; Robert I Smee
Journal:  Dysphagia       Date:  2019-02-11       Impact factor: 3.438

2.  Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.

Authors:  Natália Rangel Palmier; Adriana Franco Paes Leme; Tatiane De Rossi; Guilherme Pimentel Telles; Karina Morais-Faria; Luiz Paulo Kowalski; Gustavo Nader Marta; Thaís Bianca Brandão; Praveen R Arany; César Augusto Migliorati; Alan Roger Santos-Silva; Ana Carolina Prado-Ribeiro
Journal:  Support Care Cancer       Date:  2020-10-02       Impact factor: 3.603

3.  Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14).

Authors:  Anna Lee; Julie Kang; Yao Yu; Sean McBride; Nadeem Riaz; Marc Cohen; Eric Sherman; Loren Michel; Nancy Lee; C Jillian Tsai
Journal:  Int J Part Ther       Date:  2019-04-22

4.  The Optimization of a Novel Hydrogel-Egg White-Alginate for 2.5D Tissue Engineering of Salivary Spheroid-Like Structure.

Authors:  Yuli Zhang; Hieu M Pham; Jose G Munguia-Lopez; Joseph M Kinsella; Simon D Tran
Journal:  Molecules       Date:  2020-12-06       Impact factor: 4.411

5.  Silencing the lncRNA NORAD inhibits EMT of head and neck squamous cell carcinoma stem cells via miR‑26a‑5p.

Authors:  Weiming Hu; Yong Zhao; Lizhong Su; Zuliang Wu; Wenjing Jiang; Xiaoze Jiang; Ming Liu
Journal:  Mol Med Rep       Date:  2021-08-26       Impact factor: 2.952

Review 6.  Dosimetric justification for the use of volumetric modulated arc therapy in head and neck cancer-A systematic review of the literature.

Authors:  Nikolett Buciuman; Loredana G Marcu
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-08-16

7.  IMRT delivers lower radiation doses to dental structures than 3DRT in head and neck cancer patients.

Authors:  Eduardo Rodrigues Fregnani; Cláudia Joffily Parahyba; Karina Morais-Faria; Felipe Paiva Fonseca; Pedro Augusto Mendes Ramos; Fábio Yone de Moraes; Karina Gondim Moutinho da Conceição Vasconcelos; Gisela Menegussi; Alan Roger Santos-Silva; Thais B Brandão
Journal:  Radiat Oncol       Date:  2016-09-07       Impact factor: 3.481

Review 8.  The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review.

Authors:  Gustavo Nader Marta; Charlotte Coles; Orit Kaidar-Person; Icro Meattini; Tarek Hijal; Yvonne Zissiadis; Jean-Philippe Pignol; Duvern Ramiah; Alice Y Ho; Skye Hung-Chun Cheng; Gemma Sancho; Birgitte Vrou Offersen; Philip Poortmans
Journal:  Crit Rev Oncol Hematol       Date:  2020-08-26       Impact factor: 6.312

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.